MUFG Securities Americas’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$851K Buy
4,369
+338
+8% +$70.1K 0.04% 324
2026
Q1
$905K Buy
4,031
+99
+3% +$24.7K 0.06% 279
2025
Q4
$947K Sell
3,932
-17
-0.4% -$4.35K 0.06% 270
2025
Q3
$1.08M Buy
3,949
+699
+22% +$191K 0.07% 245
2025
Q2
$839K Buy
3,250
+651
+25% +$155K 0.07% 243
2025
Q1
$582K Buy
2,599
+432
+20% +$101K 0.07% 260
2024
Q4
$496K Buy
+2,167
New +$522K 0.06% 263

Other funds holding RMD

MUFG Securities Americas's RMD Position: Q2 2026 in Review

MUFG Securities Americas increased its ResMed (RMD) stake by 8.4% in Q2 2026, buying an estimated $70.1K and bringing the position to 4,369 shares worth $851K. The position accounts for 0.04% of the portfolio, ranked #324.

MUFG Securities Americas first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.08M in Q3 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • MUFG Securities Americas held 4,369 shares of ResMed worth $851K as of Q2 2026.
  • MUFG Securities Americas bought 338 ResMed shares in Q2 2026, an estimated $70.1K.
  • ResMed made up 0.04% of MUFG Securities Americas's portfolio in Q2 2026, its #324 holding.
  • MUFG Securities Americas first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • MUFG Securities Americas's ResMed position peaked at $1.08M in Q3 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.